5944. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.
作者: Maximilian Baumgartner.;Michaela Lang.;Hunter Holley.;Daniel Crepaz.;Bela Hausmann.;Petra Pjevac.;Doris Moser.;Felix Haller.;Fabian Hof.;Andrea Beer.;Elisabeth Orgler.;Adrian Frick.;Vineeta Khare.;Rayko Evstatiev.;Susanne Strohmaier.;Christian Primas.;Werner Dolak.;Thomas Köcher.;Kristaps Klavins.;Timo Rath.;Markus F Neurath.;David Berry.;Athanasios Makristathis.;Markus Muttenthaler.;Christoph Gasche.
来源: Gastroenterology. 2021年161卷4期1245-1256.e20页
Irritable bowel syndrome (IBS) and inflammatory bowel diseases result in a substantial reduction in quality of life and a considerable socioeconomic impact. In IBS, diagnosis and treatment options are limited, but evidence for involvement of the gut microbiome in disease pathophysiology is emerging. Here we analyzed the prevalence of endoscopically visible mucosal biofilms in gastrointestinal disease and associated changes in microbiome composition and metabolism.
5946. Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY).
作者: Laurent Peyrin-Biroulet.;Edward V Loftus.;Jean-Frédéric Colombel.;Silvio Danese.;Raquel Rogers.;Jeffrey D Bornstein.;Jingjing Chen.;Stefan Schreiber.;Bruce E Sands.;Richard A Lirio.
来源: Gastroenterology. 2021年161卷4期1156-1167.e3页
VARSITY (An Efficacy and Safety Study of Vedolizumab Intravenous [IV] Compared to Adalimumab Subcutaneous [SC] in Participants With Ulcerative Colitis) showed superior clinical remission and endoscopic improvement in ulcerative colitis with vedolizumab vs adalimumab. This analysis compared histologic outcomes.
5947. Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
作者: Michael D Kappelman.;Kimberly N Weaver.;Margie Boccieri.;Ann Firestine.;Xian Zhang.;Millie D Long.; .
来源: Gastroenterology. 2021年161卷4期1340-1343.e2页 5949. COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States.
作者: Yousaf Bashir Hadi.;Shyam Thakkar.;Sardar Momin Shah-Khan.;William Hutson.;Arif Sarwari.;Shailendra Singh.
来源: Gastroenterology. 2021年161卷4期1336-1339.e3页 5950. Peroral endoscopic myotomy and septotomy for Zenker diverticulum.
作者: Rami El Abiad.;Elizabeth Brindise.;Michael Bejjani.;Bachir Ghandour.;Mouen Khashab.
来源: Minerva Gastroenterol (Torino). 2023年69卷2期217-231页
Zenker diverticulum (ZD) is the most common hypopharyngeal diverticulum seen often in septuagenarian and octogenarian males. Oropharyngeal dysphagia is the most common presenting symptom. Treatment of ZD has been advancing with the introduction of a wide variety of accessory devices, primarily focusing on obliteration of the septum by complete transection of the cricopharyngeus muscle to recreate the common cavity and restore normal pharyngo-esophageal bolus outflow. This review aimed to provide an overview of the various surgical and endoscopic treatment options for ZD, while focusing specifically on Zenker peroral endoscopic myotomy.
5951. Endoscopic management of difficult common bile duct stones.
Common bile duct stones are a very frequent problem in the western world and endoscopic stone clearance is the method of choice for treatment. Despite its common use, endoscopic clearance of common bile duct stones is not always trivial especially in cases involving large or multiple stones.
5953. Risk of Venous Thromboembolism Among Patients With Inflammatory Bowel Disease Who Contract Severe Acute Respiratory Syndrome Coronavirus 2.
作者: Nadim Mahmud.;Alexandra Weiss.;Chinmay Trivedi.;Yu-Xiao Yang.;James Lewis.;Nabeel Khan.
来源: Gastroenterology. 2021年161卷5期1709-1711.e1页 5955. Integrated analysis of the functions and prognostic values of RNA binding proteins in hepatocellular carcinoma.
Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, ranks as the fifth most common cancer and has been the second most frequent cause of cancer-related death. RNA binding proteins (RBPs) are proteins that interact with different classes of RNA and are commonly detected in cells.
5956. The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E.
作者: Enas S Al Absi.;Duaa W Al-Sadeq.;Makiyeh Khalili.;Nadin Younes.;Nader Al-Dewik.;Sara K Abdelghany.;Somaia S Abouzid.;Asma A Al Thani.;Hadi M Yassine.;Peter V Coyle.;Gheyath K Nasrallah.
来源: BMC Gastroenterol. 2021年21卷1期266页
The rapid growth of Qatar in the last two decades has attracted a large influx of immigrant workers who mostly come from HEV-hyperendemic countries. Thus, we aim to investigate the prevalence of HEV among acute non-A-C hepatitis patients in Qatar; and to evaluate the performance of four dominant commercial serological assays for HEV diagnosis.
5958. Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
作者: Philipp K Haber.;Marc Puigvehí.;Florian Castet.;Vennis Lourdusamy.;Robert Montal.;Parissa Tabrizian.;Michael Buckstein.;Edward Kim.;Augusto Villanueva.;Myron Schwartz.;Josep M Llovet.
来源: Gastroenterology. 2021年161卷3期879-898页
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with a rapidly changing landscape of treatments. In the past 20 years, numerous randomized controlled trials (RCTs) have aimed at improving outcomes across disease stages. We aimed to analyze the current evidence and identify potential factors influencing response to therapies.
5959. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
作者: Sam Nooij.;Quinten R Ducarmon.;Jeroen F J Laros.;Romy D Zwittink.;Jason M Norman.;Wiep Klaas Smits.;Hein W Verspaget.;Josbert J Keller.;Elisabeth M Terveer.;Ed J Kuijper.; .
来源: Gastroenterology. 2021年161卷4期1218-1228.e5页
Patients with multiple recurrent Clostridioides difficile infection (rCDI) have a disturbed gut microbiota that can be restored by fecal microbiota transplantation (FMT). Despite extensive screening, healthy feces donors may carry bacteria in their intestinal tract that could have long-term health effects, such as potentially procarcinogenic polyketide synthase-positive (pks+) Escherichia coli. Here, we aim to determine whether the pks abundance and persistence of pks+E coli is influenced by pks status of the donor feces.
5960. Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis.
作者: Jennifer M Kolb.;Junxiao Hu.;Kristen DeSanto.;Dexiang Gao.;Siddharth Singh.;Thomas Imperiale.;David A Lieberman.;C Richard Boland.;Swati G Patel.
来源: Gastroenterology. 2021年161卷4期1145-1155.e12页
Incidence and mortality associated with early-age onset colorectal cancer (EAO-CRC) is increasing, prompting professional society recommendations to lower the screening age in average-risk individuals. The yield of screening individuals younger than 50 years is not known.
|